The FDA Orange Book lists no approved generic equivalent of Ozempic in the United States [1]. The differences between Ozempic and Wegovy matter because use and dosage depend on the product and its label. Both brand names contain semaglutide.
What a compounded prescription means
A compounded drug does not undergo FDA premarket review for safety, effectiveness or quality [2]. The evidence on compounded semaglutide depends on the formulation actually dispensed. FDA advises using compounded drugs only when an available approved medication cannot meet a patient's medical needs.
An offer advertised as generic Ozempic does not establish what the seller dispenses. Our guide to checking for counterfeit Ozempic explains what product and pharmacy details to verify. A pharmacist can confirm the exact name, formulation and manufacturer before filling the prescription.
What an Indian trial found
A randomized trial in India compared one manufacturer's synthetic semaglutide injection with Wegovy for weight management [3]. Average weight loss at week 24 was 13.8% with the test product and 14.1% with Wegovy. The estimated difference was 0.26 percentage points, with a 95% confidence interval from −0.86 to 1.39.
The upper end of the confidence interval was below the prespecified margin of 4.5 percentage points. That met the trial's criterion for noninferiority on the weight endpoint. The comparison applies to those specific injections over 24 weeks. The test product’s manufacturer funded the study. The trial did not establish whether a US compounded preparation performs similarly or whether the test injection can substitute for Ozempic.